Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer group.

Autor: Seufferlein T; Department of Internal Medicine I, Ulm University, Ulm, Germany. Electronic address: thomas.seufferlein@uniklinik-ulm.de., Uhl W; Department of General and Visceral Surgery, St. Josef-Hospital Bochum, Ruhr-University Bochum, Bochum, Germany., Kornmann M; Department of General and Visceral Surgery, Ulm University, Ulm, Germany., Algül H; CCC Munich-TUM and Department of Internal Medicine II, TUM, Munich, Germany., Friess H; Department of General and Visceral Surgery, TUM, Munich, Germany., König A; Department of Gastroenterology, GI-Oncology and Endocrinology, University Medical Center, Göttingen, Germany., Ghadimi M; Department of General and Visceral Surgery, University Medical Center Göttingen, Göttingen, Germany., Gallmeier E; Department of Gastroenterology and Endocrinology, University of Marburg, Marburg, Germany., Bartsch DK; Department of General and Visceral Surgery, University of Marburg, Marburg, Germany., Lutz MP; Department of Gastroenterology, Caritasklinik St. Theresia, Saarbrücken, Germany., Metzger R; Department of General and Visceral Surgery, Caritasklinik St. Theresia, Saarbrücken, Germany., Wille K; Department of Hematology, Oncology, Hemostaseology and Palliative Care, Johannes Wesling Medical Center Minden, Ruhr-University Bochum, Bochum, Germany., Gerdes B; Department of General and Visceral Surgery Minden, Ruhr-University Bochum, Minden, Germany., Schimanski CC; Department of Internal Medicine and Gastroenterology, Darmstadt Hospital, Darmstadt, Germany., Graupe F; Department of General and Visceral Surgery, Darmstadt Hospital, Darmstadt, Germany., Kunzmann V; Department of Internal Medicine II, Julius Maximilians University, Würzburg, Germany., Klein I; Department of General, Visceral, Vascular and Pediatric Surgery, Julius Maximilians University, Würzburg, Germany., Geissler M; Department of Hematology and Oncology, Esslingen Hospital, Esslingen, Germany., Staib L; Department of Surgery, Esslingen Hospital, Esslingen, Germany., Waldschmidt D; Department of Gastroenterology and Hepatology, University of Cologne, Cologne, Germany., Bruns C; Department of Visceral Surgery, University of Cologne, Cologne, Germany., Wittel U; Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany., Fichtner-Feigl S; Department of General and Visceral Surgery, University of Freiburg, Freiburg, Germany., Daum S; Department for Gastroenterology, Rheumatology and Infectology, Charite University Hospital Berlin, Berlin, Germany., Hinke A; Biostatistics, CCRC Cancer Clinical Research Consulting, Düsseldorf, Germany., Blome L; Biometrics, ClinAssess Gesellschaft für klinische Forschung mbH, Leverkusen, Germany., Tannapfel A; Institute of Pathology, Ruhr-University Bochum, Bochum, Germany., Kleger A; Department of Internal Medicine I, Ulm University, Ulm, Germany., Berger AW; Department of Internal Medicine I, Ulm University, Ulm, Germany., Kestler AMR; Department of Internal Medicine I, Ulm University, Ulm, Germany., Schuhbaur JS; Department of Internal Medicine I, Ulm University, Ulm, Germany., Perkhofer L; Department of Internal Medicine I, Ulm University, Ulm, Germany., Tempero M; UCSF Department of Medicine, University of California San Francisco, San Francisco, USA., Reinacher-Schick AC; Department of Hematology, Oncology and Palliative Care, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany., Ettrich TJ; Department of Internal Medicine I, Ulm University, Ulm, Germany.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Jan; Vol. 34 (1), pp. 91-100. Date of Electronic Publication: 2022 Oct 07.